Year: 2019
Type: erratum
Abstract: The author would like to draw the reader's attention to errors in the following article: Figure 2 Serial changes in fasting plasma glucose (FPG), glycated hemoglobin (HbA1c), and body mass index (BMI) in type 2 diabetes patients with non-alcoholic fatty liver disease during 24 weeks of treatment with luseogliflozin. *P < 0.01, **P < 0.0001, ***P < 0.00001, #P < 0.05, ##P < 0.01 versus 0 weeks. [Color figure can be viewed at wileyonlinelibrary.com]. The authors apologize for the errors.
Source: Hepatology Research
DOI: 10.1111/hepr.13406
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4244571770
